The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma
Abstract
Purpose: We have previously demonstrated a significant negative impact of intratumoral neutrophils in metastatic renal cell carcinoma. This study assessed intratumoral neutrophils in localized clear cell renal cell carcinoma (RCC). Patients and Methods: The study comprised 121 consecutive patients who had a nephrectomy for localized RCC. Biomarkers (intratumoral CD8+, CD57+ immune cells, CD66b+ neutrophils, and carbonic anhydrase IX [CA IX]) were assessed by immunohistochemistry, and the relationship with clinical and histopathologic features and patient outcome was evaluated. Results: The intratumoral neutrophils ranged from zero to 289 cells/mm 2 tumor tissue. The presence of intratumoral neutrophils was statistically significantly associated with increasing tumor size, low hemoglobin, high creatinine, and CA IX ≤ 85%. In multivariate analysis, the presence of intratumoral neutrophils (hazard ratio [HR], 3.0; 95% CI, 1.7 to 5.4; P < .0001), pT stage T3b/T4 (HR, 2.1; 95% CI, 1.2 to 3.6; P = .007), and low hemoglobin (HR, 1.8; 95% CI, 1.0 to 3.1; P = .03) were independent prognostic factors significantly associated with short recurrence-free survival. The presence of intratumoral neutrophils was also an independent prognostic factor for cancer-specific survival (HR, 3.5; 95% CI, 1.9 to 6.4; P < .0001) and overall survival (HR, 3.1; 95% CI, 1.9 to 5.0; P < .0001). Applying the prognostic value of intratumoral neutrophils to the Leibovich low-/intermediate-risk group (n = 78) showed a 5-year recurrence-free survival of 53% (95% CI, 34.6% to 71.8%; presence of intratumoral neutrophils) versus 87% (95% CI, 77.8% to 96.8%; absence of intratumoral neutrophils). The estimated concordance index was 0.74 using the Leibovich risk score and 0.80 when intratumoral neutrophils were added. Conclusion: The presence of intratumoral neutrophils is a new, strong, independent prognostic factor for short recurrence-free, cancer-specific, and overall survival in localized clear cell RCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Evaluating the Yield of Medical Tests
Harrell, F. E. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03320430047030 · Cited by 3,490
GUNDERSEN, H. J. G., BENDTSEN, T. F., KORBO, L., MARCUSSEN, N., MØLLER, A., NIELSEN, K., NYENGAARD, J. R., PAKKENBERG, B., SØRENSEN, F. B., VESTERBY, A., et al. (1988) · APMIS · doi:10.1111/j.1699-0463.1988.tb05320.x · Cited by 2,929
Self-citationPrognostic significance of morphologic parameters in renal cell carcinoma
Fuhrman, S. A., Lasky, L. C., & Limas, C. (1982) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198210000-00007 · Cited by 2,724
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
FRANK, I., BLUTE, M. L., CHEVILLE, J. C., LOHSE, C. M., WEAVER, A. L., & ZINCKE, H. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64153-5 · Cited by 1,175
Classification of renal cell carcinoma: Workgroup No. 1
St�rkel, S., Eble, J. N., Adlakha, K., Amin, M., Blute, M. L., Bostwick, D. G., Darson, M., Delahunt, B., & Iczkowski, K. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970901)80:5<987::aid-cncr24>3.0.co;2-r · Cited by 864
Zea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D., Quiceno, D., Youmans, A., O'Neill, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4505 · Cited by 851
Leibovich, B. C., Blute, M. L., Cheville, J. C., Lohse, C. M., Frank, I., Kwon, E. D., Weaver, A. L., Parker, A. S., & Zincke, H. (2003) · Cancer · doi:10.1002/cncr.11234 · Cited by 837
A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA
KATTAN, M. W., REUTER, V., MOTZER, R. J., KATZ, J., & RUSSO, P. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)66077-6 · Cited by 754
Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System
Zisman, A., Pantuck, A. J., Dorey, F., Said, J. W., Shvarts, O., Quintana, D., Gitlitz, B. J., deKernion, J. B., Figlin, R. A., & Belldegrun, A. S. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1649 · Cited by 729
BUI, M. H. T., Seligson, D. B., Han, K. R., Pantuck, A. J., Dorey, F. J., Huang, Y., Horvath, S., Leibovich, B. C., Chopra, S., Liao, S. Y., et al. (2003) · PubMed · Cited by 654
Mantovani, A. (2009) · Nature · doi:10.1038/457036b · Cited by 643
Thompson, R. H., Dong, H., Lohse, C. M., Leibovich, B. C., Blute, M. L., Cheville, J. C., & Kwon, E. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2599 · Cited by 569
Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma
Ochoa, A. C., Zea, A. H., Hernandez, C., & Rodriguez, P. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2197 · Cited by 489
Patard, J.-J., Kim, H. L., Lam, J. S., Dorey, F. J., Pantuck, A. J., Zisman, A., Ficarra, V., Han, K.-R., Cindolo, L., De La Taille, A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.104 · Cited by 423
Immune cells as mediators of solid tumor metastasis
DeNardo, D. G., Johansson, M., & Coussens, L. M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9100-0 · Cited by 372
Kono, K., Salazar‐Onfray, F., Petersson, M., Hansson, J., Masucci, G., Wasserman, K., Nakazawa, T., Anderson, P., & Kiessling, R. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260620 · Cited by 359
STAGE SPECIFIC GUIDELINES FOR SURVEILLANCE AFTER RADICAL NEPHRECTOMY FOR LOCAL RENAL CELL CARCINOMA
LEVY, D. A., SLATON, J. W., SWANSON, D. A., & DINNEY, C. P. N. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63541-9 · Cited by 351
Négrier, S., Escudier, B., Gomez, F., Douillard, J.-Y., Ravaud, A., Chevreau, C., Buclon, M., Pérol, D., & Lasset, C. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf257 · Cited by 343
Schmidt, H., Bastholt, L., Geertsen, P., Christensen, I. J., Larsen, S., Gehl, J., & von der Maase, H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602702 · Cited by 329
Self-citationImpact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma
Donskov, F., & von der Maase, H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.9594 · Cited by 299
Self-citationCrispen, P. L., Sheinin, Y., Roth, T. J., Lohse, C. M., Kuntz, S. M., Frigola, X., Thompson, R. H., Boorjian, S. A., Dong, H., Leibovich, B. C., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0536 · Cited by 272
Metastatic renal carcinoma comprehensive prognostic system
and DGCIN - German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group, Atzpodien, J., Royston, P., Wandert, T., & Reitz, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600768 · Cited by 241
Choueiri, T. K., Garcia, J. A., Elson, P., Khasawneh, M., Usman, S., Golshayan, A. R., Baz, R. C., Wood, L., Rini, B. I., & Bukowski, R. M. (2007) · Cancer · doi:10.1002/cncr.22827 · Cited by 228
Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites
Hansson, M., Asea, A., Ersson, U., Hermodsson, S., & Hellstrand, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.42 · Cited by 209
Polarized immune responses differentially regulate cancer development
Johansson, M., DeNardo, D. G., & Coussens, L. M. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00600.x · Cited by 209
Expression of MaTu‐MN protein in human tumor cultures and in clinical specimens
Závada, J., Závadová, Z., Pastoreková, S., Čiampor, F., Pastorek, J., & Zelník, V. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540218 · Cited by 204
Leibovich, B. C., Sheinin, Y., Lohse, C. M., Thompson, R. H., Cheville, J. C., Zavada, J., & Kwon, E. D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.1087 · Cited by 196
Schmidt, H., Suciu, S., Punt, C. J. A., Gore, M., Kruit, W., Patel, P., Lienard, D., von der Maase, H., Eggermont, A. M. M., & Keilholz, U. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0274 · Cited by 190
Self-citationZigeuner, R., Hutterer, G., Chromecki, T., Imamovic, A., Kampel-Kettner, K., Rehak, P., Langner, C., & Pummer, K. (2010) · European Urology · doi:10.1016/j.eururo.2008.11.033 · Cited by 180
Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinoma
Thompson, R. H., Gillett, M. D., Cheville, J. C., Lohse, C. M., Dong, H., Webster, W. S., Chen, L., Zincke, H., Blute, M. L., Leibovich, B. C., et al. (2005) · Cancer · doi:10.1002/cncr.21470 · Cited by 174
Bromwich, E. J., McArdle, P. A., Canna, K., McMillan, D. C., McNicol, A.-M., Brown, M., & Aitchison, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601400 · Cited by 162
Molecular mechanisms of carbonic anhydrase IX‐mediated pH regulation under hypoxia
Pastoreková, S., Ratcliffe, P. J., & Pastorek, J. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07642.x · Cited by 111
Crispen, P. L., Boorjian, S. A., Lohse, C. M., Leibovich, B. C., & Kwon, E. D. (2008) · Cancer · doi:10.1002/cncr.23566 · Cited by 96
Webster, W. S., Lohse, C. M., Thompson, R. H., Dong, H., Frigola, X., Dicks, D. L., Sengupta, S., Frank, I., Leibovich, B. C., Blute, M. L., et al. (2006) · Cancer · doi:10.1002/cncr.21951 · Cited by 86
Prognostic factors and selection for clinical studies of patients with kidney cancer
Lam, J. S., Klatte, T., Kim, H. L., Patard, J., Breda, A., Zisman, A., Pantuck, A. J., & Figlin, R. A. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.08.003 · Cited by 81
Donskov, F. N., Hokland, M., Marcussen, N., Madsen, H. H. T., & von der Maase, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602937 · Cited by 72
Self-citationZhao, L., Xu, S., Fjaertoft, G., Pauksen, K., Håkansson, L., & Venge, P. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.08.009 · Cited by 70
Yamashita, J., Ogawa, M., & Shirakusa, T. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.3.375 · Cited by 56
Lamb, G. W. A., McArdle, P., Ramsey, S., McNichol, A., Edwards, J., Aitchison, M., & McMillan, D. C. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07666.x · Cited by 52
Kolbeck, P. C., Kaveggia, F. F., Johansson, S. L., Grune, M. T., & Taylor, R. J. (1992) · PubMed · Cited by 50
Atzpodien, J., & Reitz, M. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.0429 · Cited by 43
Donskov, F. N., Bennedsgaard, K. M., Hokland, M., Marcussen, N., Fisker, R. V., Madsen, H. H. T., Fode, K., & von der Maase, H. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0525-9 · Cited by 42
Self-citationMichael, M., Goldstein, D., Clarke, S. J., Milner, A. D., Beale, P. J., Friedlander, M. L., & Mitchell, P. (2006) · Clinical Colorectal Cancer · doi:10.3816/ccc.2006.n.048 · Cited by 35
Soyupek, S., Tulunay, Ö., Armağan, A., Hoşcan, M. B., & Perk, H. (2007) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590701303645 · Cited by 7
Cited by
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
“Human tumours can be infiltrated by mature granulocytes, the numbers of which can be independent prognostic factors for tumour recurrenc”
BackgroundNeutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830
Neutrophil Function: From Mechanisms to Disease
Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D., & Zychlinsky, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074942 · Cited by 1,708
The multifaceted functions of neutrophils
Mayadas, T. N., Cullere, X., & Lowell, C. A. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164023 · Cited by 1,356
“Most clinical observations suggest that the presence of abundant neutrophils within a tumor bed is associated with increased tumor growth and hence a poor prognosis (236).”
Gooden, M. J. M., de Bock, G. H., Leffers, N., Daemen, T., & Nijman, H. W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.189 · Cited by 1,277
Metadata
- Authors
- Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., & von der Maase, H.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-10-01
- Volume
- 27
- Issue
- 28
- Pages
- 4709-4717
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2111960266
- Cited by
- 461
- References
- 47
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.